Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Its products are sold worldwide to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. It manufactures products in the United States of America, Puerto Rico and in six foreign countries. The Company launched a subcutaneous formulation of ORENCIA (abatacept) in the United States of America, NULOJIX (belatacept) in the United States of America and the European Union for the prevention of organ rejection in adult patients receiving a kidney transplant. In September 2011, it acquired the Amira Pharmaceuticals, Inc. (Amira).... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Bristol-Myers Squibb?